Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (BOOSTER)
Phase I Dose Escalation Study of Stereotactic BOOST for Prostate cancER
Sponsor: Royal North Shore Hospital
A NA clinical study on Prostate Cancer, this trial is completed. The trial is conducted by Royal North Shore Hospital and has accumulated 8 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Phase: PHASE1 → NA
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE1
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 3 earlier versions
-
Feb 2019 — Oct 2019 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Royal North Shore Hospital
For direct contact, visit the study record on ClinicalTrials.gov .